While academic and popular debates tend to focus on differential benefits and costs of trade across countries or industries, this brief highlights winners and losers at the level of individual firms. The authors demonstrate that preferential liberalization produces concentrated benefits among a relatively small number of very large and productive firms.
Pablo M. Pinto, Leonardo Baccini, Stephen WeymouthNovember 21, 2017
With the Texas Legislature now considering several bills that would decrease penalties for marijuana possession and legalize the use of medical marijuana to treat a variety of conditions, authors William Martin and Katharine A. Neill present updated findings in this new issue brief that support the case for reforming marijuana policy in Texas.
Katharine Neill Harris, William MartinMarch 10, 2017
Drug Policy Program director Bill Martin summarizes the scientific and fiscal evidence supporting the efficacy of syringe exchange programs and outlines a framework for public policies to deal with this aspect of drug use and abuse.
Using charts, figures and graphs of this survey data originally created by former career intelligence analyst Brian C. Bennett and updated by the Drug Policy Program, this issue brief offers an overview of drug use trends in America over the last four decades. The brief is part of a larger online project chronicling the pattern of the use and abuse of individual drugs over (in most cases) more than 40 years.
William Martin, Katharine Neill HarrisAugust 1, 2016
Despite enviable increases in educational attainment, women in the MENA countries may fare less well in attaining a form of social capital integral to their ability to exercise full political, economic and social agency: wasta — loosely, clout, or using one’s connections and/or influence to get things done.
As the BRICS hold their seventh summit in Ufa, Russia this week, international economics fellow Russell Green and Rice student Elisabeth Kalomeris offer advice on designing the framework for the organization’s New Development Bank.
In 1972, a National Commission on Marihuana and Drug Abuse, comprising establishment figures chosen mostly by President Richard Nixon himself, issued a report that declared that “neither the marihuana user nor the drug itself can be said to constitute a danger to public safety” and recommended that Congress and state legislatures decriminalize the use and casual distribution of marijuana and seek means other than prohibition to discourage use.
President Nixon ignored the report and Congress declined to consider its recommendations, but during the 40-plus years since its publication, at least 37 states have acted to refashion a crazy-quilt collection of prohibitions, nearly always in the direction favored by the commission. The specifics vary by state, but most reform legislation has followed one of three formulas: decriminalization of marijuana possession, legalization of marijuana for medical use, or legalization of marijuana for adult recreational use. In this issue brief, authors Katharine Neill and William Martin examine the facts and fears surrounding each of these options.
Katharine Neill Harris, William MartinFebruary 4, 2015